From 2013 to 2023, the value of high-tech pharmaceutical products imported to Sweden exhibited a generally upward trend, beginning at 1.18 billion euros in 2013 and reaching 2.79 billion euros in 2023. Although there were minor declines in 2013 and 2014, the overall trend shows significant growth, particularly from 2018 onwards, demonstrating a compound annual growth rate (CAGR) of 11.51% over the last five years.
Key Year-on-Year Variations:
- 2021: 18.93%
- 2022: 7.99%
- 2023: 8.37%
The forecasted growth continues this trend, with an expected CAGR of 4.98% from 2024 to 2028. By 2028, the value is projected to reach 3.83 billion euros, representing a 27.52% growth over the five-year forecast period.
Future trends to watch for include innovations in pharmaceutical technology, potential shifts in international trade policies, and changes in healthcare regulations, all of which could influence import patterns and overall market dynamics in Sweden.
